Skip to content
OpenCapital
Get started

MoonLake Immunotherapeutics MLTX Increase (Decrease) In Operating Lease, Right-Of-Use Asset

Increase (Decrease) In Operating Lease, Right-Of-Use Asset at other companies

HQY
HealthEquityHQY
-$1.73M-5.0%
The Baldwin Insurance Group, Inc. logo
The Baldwin Insurance Group, Inc.BWIN
-$4M+4.2%
Virtu Financial logo
Virtu FinancialVIRT
-$12.43M-5.2%
ABM Industries logo
ABM IndustriesABM
-$3M-76.5%
Virtu Financial logo
Virtu FinancialVIRT
-$12.43M-5.2%
Dolby Laboratories, Inc. logo
Dolby Laboratories, Inc.DLB
$12.37M—

Other financials

Income statement

See full
Operating income-$70.0M-47.5%
Net income-$69.7M-74.5%
EPS (diluted)-$0.98-55.6%

Balance sheet

See full
Cash & equivalents$298.5M+9.9%
Total debt$100.8M+33.3%
Total equity$254.0M-37.7%
Total assets$400.4M-21.7%

Cash flow

See full
Operating cash flow-$66.3M-73.8%
CapEx--100%
Free cash flow-$66.3M-73.6%

Valuation

See full
Market cap$1.56B-45.9%
Enterprise value$1.36B-50.0%

Returns & leverage

See full
Return on equity-77.7%-221pp
Debt / equity0.4×+0.2×
Current ratio8.6×-12.5×

Where this comes from

Reported directly by MoonLake Immunotherapeutics in its filing.

Tagged under the XBRL concept mnlk:IncreaseDecreaseInOperatingLeaseRightOfUseAsset.

The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about MoonLake Immunotherapeutics's increase (decrease) in operating lease, right-of-use asset.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MoonLake Immunotherapeutics's increase (decrease) in operating lease, right-of-use asset?
MoonLake Immunotherapeutics (MLTX) reported increase (decrease) in operating lease, right-of-use asset of $30K in Q1 2026.
What does increase (decrease) in operating lease, right-of-use asset mean?
This metric represents the net change in the carrying value of right-of-use assets associated with operating leases during the reporting period. It reflects adjustments for lease modifications, impairments, or changes in lease terms that impact the balance sheet. Monitoring this helps investors understand the company's commitment to leased infrastructure and its impact on non-cash operating activities.